GlassScriptPhysician profile
Nancy B Davis
NPI 1164718003
$2,935.59
in general payments reported to CMS, 2019-2025
33 companies · $20.84 in 2025
The $20.84 reported for 2025 was less than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,941 · 2022: $884 · 2023: $65.94 · 2024: $23.99 · 2025: $20.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $586.55 | 2021-2022 | |
| Abbott Laboratories | $195.50 | 2021-2023 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $193.26 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $152.40 | 2021-2022 | |
| Lilly USA, LLC | $151.88 | 2021-2022 | |
| Amgen INC. | $135.40 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $109.40 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $104.75 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $103.68 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $97.88 | 2021-2022 | |
| Novo Nordisk INC | $93.51 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.55 | 2021-2022 | |
| Exact Sciences Corporation | $86.35 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $81.20 | 2021-2022 | |
| Eisai INC. | $76.41 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $75.96 | 2021 | |
| Janssen Pharmaceuticals, INC | $73.56 | 2021 | |
| Dexcom, INC. | $64.75 | 2021-2022 | |
| Genentech USA, INC. | $58.78 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.31 | 2021-2022 | |
| Antares Pharma, INC. | $46.19 | 2021-2022 | |
| Daiichi Sankyo INC. | $41.72 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.21 | 2022 | |
| Amarin Pharma, INC. | $33.51 | 2022 | |
| Adlon Therapeutics L.P. | $28.59 | 2021 | |
| Jazz Pharmaceuticals INC. | $26.37 | 2021 | |
| Currax Pharmaceuticals LLC | $25.86 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $25.27 | 2021 | |
| Aytu Biopharma, INC. | $18.42 | 2021 | |
| Lundbeck LLC | $17.78 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.19 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.